Small-scale dissolution test screening tool to select potentially substandard and falsified (SF) medicines requiring full pharmacopoeial analysis

Small-scale dissolution test screening tool to select potentially substandard and falsified (SF) medicines requiring full pharmacopoeial analysis

Abstract The purpose of this study was to design a convenient, small-scale dissolution test for extracting potential substandard and falsified (SF) medicines that require full pharmacopoeial analysis. The probability of metronidazole samples complying with the US Pharmacopoeia (USP) dissolution test...

Full description

Bibliographic Details
Main Authors:	Mohammad Sofiqur Rahman, Naoko Yoshida, Hirohito Tsuboi, Yuichiro Ishii, Yoshio Akimoto, Kazuko Kimura
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-06-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-91443-5

Similar Items

Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020-03-01)

Discrimination of Falsified Erectile Dysfunction Medicines by Use of an Ultra-Compact Raman Scattering Spectrometer
by: Tomoko Sanada, et al.
Published: (2020-12-01)

Trade in substandard and falsified medicines
by: Hagen, N, et al.
Published: (2022)

Patient safety and public health concerns: poor dissolution rate of pioglitazone tablets obtained from China, Myanmar and internet sites
by: Mohammad Sofiqur Rahman, et al.
Published: (2021-03-01)

How to achieve international action on falsified and substandard medicines.
by: Attaran, A, et al.
Published: (2012)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
by: Zabala, GA, et al.
Published: (2022)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
by: Paul N Newton, et al.
Published: (2022-08-01)

The economic impact of substandard and falsified antimalarial medications in Nigeria.
by: Sarah M Beargie, et al.
Published: (2019-01-01)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
by: Robin Rojas-Cortés
Published: (2020-10-01)

Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
by: Kathryn D. Jackson, et al.
Published: (2020-07-01)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
by: Tabernero, P, et al.
Published: (2019)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
by: Cavany, S, et al.
Published: (2023)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
by: Tabernero, P, et al.
Published: (2022)

The concept of substandard (falsified and poor quality) industrial products and its types
by: K. A. Utarov, et al.
Published: (2022-09-01)

The concept of substandard (falsified and poor quality) industrial products and its types
by: K. A. Utarov, et al.
Published: (2022-09-01)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
by: Sean Cavany, et al.
Published: (2023-10-01)

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
by: Elizabeth Pisani, et al.
Published: (2021-08-01)

Technologies for detecting falsified and substandard drugs in low and middle-income countries.
by: Stephanie Kovacs, et al.
Published: (2014-01-01)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
by: Yusuf Hassan Wada, et al.
Published: (2022-06-01)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
by: Faris El-Dahiyat, et al.
Published: (2021-10-01)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
by: Waleed M. Sweileh
Published: (2021-09-01)

Mobile apps for detecting falsified and substandard drugs: A systematic review.
by: Agustín Ciapponi, et al.
Published: (2021-01-01)

A Cross-Sectional Investigation for Verification of Globalization of Falsified Medicines in Cambodia, Indicated by Tablets of Sildenafil Citrate
by: Naoko Yoshida, et al.
Published: (2019-08-01)

Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa
by: Aukje K Mantel-Teeuwisse, et al.
Published: (2021-02-01)

Hydrodynamics and mechanical stresses in pharmacopoeial and noncompendial dissolution testing
by: Marcela Wiater, et al.
Published: (2020-06-01)

Exploring pharmacists' perspectives about substandard and falsified medical products through interviews
by: A. Persson, et al.
Published: (2024-03-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review
by: Addisu Afrassa Tegegne, et al.
Published: (2024-01-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review.
by: Addisu Afrassa Tegegne, et al.
Published: (2024-01-01)

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
by: Tamara Akpobolokemi, et al.
Published: (2022-01-01)

The Future of Falsified and Substandard Medicine Detection: Digital Methods To Track and Authenticate Pharmaceutical Products
by: Naughton, B
Published: (2018)

Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
by: Hauk, C, et al.
Published: (2021)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study.
by: Colleen R Higgins, et al.
Published: (2023-01-01)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study
by: Colleen R. Higgins, et al.
Published: (2023-01-01)

Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy.
by: Graham Lawson, et al.
Published: (2018-01-01)

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
by: Albert Petersen, et al.
Published: (2017-01-01)

A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
by: Daariimaa Khurelbat, et al.
Published: (2020-05-01)

Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study
by: Hui-Han Chen, et al.
Published: (2021-03-01)

Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community
by: Stanislav Kniazkov, et al.
Published: (2020-12-01)

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
by: McManus, D, et al.
Published: (2020)

Uncovering the Quality Deficiencies with Potentially Harmful Effects in Substandard and Falsified PDE-5 Inhibitors Seized by Belgian Controlling Agencies
by: Celine Vanhee, et al.
Published: (2023-07-01)